Effects of AZD 7009 on the atrial fibrillatory rate in patients with permanent atrial fibrillation

Trial Profile

Effects of AZD 7009 on the atrial fibrillatory rate in patients with permanent atrial fibrillation

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2013

At a glance

  • Drugs AZD 7009 (Primary)
  • Indications Atrial fibrillation
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 12 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top